FemTech
You invent innovative solutions, and we pave the path to market adoption.
For too long, solutions for women’s health issues have been underfunded, under-researched, and treated as an afterthought.
The result is fragmented markets where even the most brilliant Innovations struggle to find traction.
Success in the space requires more than great technology; it demands engagement with the full ecosystem: patients who need better solutions, providers who deliver care, investors who fund growth, and advocates who drive awareness.
These invitation-only gatherings are designed to foster deeper dialogue and relationship-building in an intimate setting. The guest list is limited. If approved, attendees will receive formal confirmation.
The FemTech category spans far beyond what is traditionally labeled “women’s health.” It includes cardiovascular disease (the leading cause of death for women) and autoimmune conditions that disproportionately impact females. Across these and countless other areas, the opportunities for innovation are vast. Yet systemic gaps remain:
- Women were excluded from clinical trials in the U.S. until 1993, creating decades of data gaps
- Just a fraction of healthcare research and innovation addresses female-specific conditions beyond oncology
- Investors and ecosystem players are actively seeking solutions, but founders must navigate complex regulatory, clinical, and commercial pathways
BD + MT combines deep ecosystem knowledge with strategic execution to help you:
- Engage Key Opinion Leaders who validate your technology and open doors to health systems
- Navigate regulatory and reimbursement pathways unique to women’s health
- Build credibility with investors actively seeking FemTech opportunities
- Connect with patients and advocates who drive awareness and demand
Explore insights from top FemTech investors and innovators leading the market.
End-to-End Services by Local U.S. Team:
Our integrated approach brings together every capability you need to enter, expand, and commercialize in the U.S. and new markets, all delivered by a team with deep local expertise.